BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

57 hedge funds and large institutions have $21.4M invested in BRAINSTORM CELL THERAPUTC in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-18
Holders Change %
-24%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
24
Closed
27
Calls
$4.23M
Puts
$4.43M
Net Calls
-$197K
Net Calls Change
+$1.5M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.41M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$529K
3
E
3
Ergoteles
New York
$472K
4
SM
4
Sabby Management
Florida
$923K
5
TEE
5
Tibra Equities Europe
United Kingdom
$331K

Top Sellers

1
BlackRock
1
BlackRock
New York
$1.8M
2
State Street
2
State Street
Massachusetts
$329K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Northern Trust
4
Northern Trust
Illinois
$189K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
US Bancorp
76
US Bancorp
Minnesota
– -$11K -200 Closed
AIP
77
Ameritas Investment Partners
Nebraska
– -$9K -157 Closed
VFA
78
Valeo Financial Advisors
Indiana
– -$6K -97 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
– -$3K -62 Closed
SFS
80
Sowell Financial Services
Arkansas
– -$1K -30 Closed
OSAM
81
O'Shaughnessy Asset Management
Connecticut
– -$1K -9 Closed
1 2 3
4